Illumina Inc. (NASDAQ: ILMN) is a large market cap stock with a market cap of 25276.64. It is in the Biotechnology industry and sector Healthcare, with a current P/E of 59.2, a forward P/E of 42.15 and EPS of 2.91. At a stock price of 172.21 (1.61%) it has a dividend yield of *TBA.
EPS growth for the last five years have been 28.90%, more recently this last year it has grown by 30.50%. The next year growth is going to be about 15.75% and more long-term 15.97% after five years. EPS growth quarter over quarter is 18.60%. Sales growth for the past five years have been 19.70% and sales growth quarter over quarter is 11.30%.
For performance, Illumina Inc. the past week has seen a gain of 0.31%. For the last month performance for Illumina Inc. is 3.48%. While the last quarter is 19.71% and half year, 14.62%. Finally for the year, performance is -14.72%.
The 52-week high for Illumina Inc., is at -19.25%, and for the 52-week low it comes to a value of 35.49%. The 20-day simple moving average is 11.57% and 9.13% for the 200-day simple moving average.
Volatility for the week is at 3.00%, and for the month it is 2.83%. Illumina Inc., has a target price of 154.25.
In terms of debt, long term debt/equity is 0.5, and for total debt/equity Illumina Inc. has 0.5. The gross margin is 70.00%, while operating margin is 24.60%, the profit margin is 18.70%. The current ratio is 3.7 and the quick ratio is 3.1.
Insider ownership is at 1.20%, with instituitional ownership at 97.70%. Illumina Inc. has a payout ratio of 0.00%. With the total shares outstanding coming to 146.78. The shares float is 145.1, with the float short at 4.20%, with short ratio coming to 5.09.
In terms of returns, the return on assets see Illumina Inc., get 11.40%, with its returns on investment at 16.60%. Return on equity is 22.10%. So will the investors see the target price of 154.25, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.